Technical Analysis for SNDX - Syndax Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 5.78 -4.30% -0.26
SNDX closed down 4.3 percent on Friday, January 18, 2019, on 52 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical SNDX trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Wide Bands Range Expansion -4.30%
Jan 17 Overbought Stochastic Strength -4.30%
Jan 16 Wide Bands Range Expansion -10.80%
Jan 16 Overbought Stochastic Strength -10.80%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -8.83%
Jan 15 Inside Day Range Contraction -8.83%
Jan 15 Wide Bands Range Expansion -8.83%
Jan 15 Overbought Stochastic Strength -8.83%

Older signals for SNDX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company's lead product candidate is entinostat, an epigenetic therapy for treatment-resistant cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. Its Entinostat is an oral histone deacetylase inhibitor that targets cancer cell growth and resistance pathways that limit the effectiveness and durability of cancer therapies. The company has a collaborative research and development agreement with the National Cancer Institute; and Genentech. Syndax Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Waltham, Massachusetts.
Is SNDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.2
52 Week Low 3.39
Average Volume 241,415
200-Day Moving Average 7.2656
50-Day Moving Average 5.0156
20-Day Moving Average 5.0855
10-Day Moving Average 6.043
Average True Range 0.4467
ADX 31.08
+DI 29.068
-DI 16.6957
Chandelier Exit (Long, 3 ATRs ) 5.3399
Chandelier Exit (Short, 3 ATRs ) 4.7301
Upper Bollinger Band 7.1326
Lower Bollinger Band 3.0384
Percent B (%b) 0.67
BandWidth 80.507325
MACD Line 0.394
MACD Signal Line 0.2692
MACD Histogram 0.1248
Fundamentals Value
Market Cap 128.42 Million
Num Shares 22.2 Million
EPS -2.84
Price-to-Earnings (P/E) Ratio -2.04
Price-to-Sales 191.23
Price-to-Book 2.13
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.37
Resistance 3 (R3) 6.42 6.28 6.27
Resistance 2 (R2) 6.28 6.13 6.25 6.23
Resistance 1 (R1) 6.03 6.04 5.96 5.98 6.20
Pivot Point 5.89 5.89 5.86 5.86 5.89
Support 1 (S1) 5.64 5.74 5.57 5.59 5.36
Support 2 (S2) 5.50 5.65 5.47 5.33
Support 3 (S3) 5.25 5.50 5.29
Support 4 (S4) 5.20